Tarceva Lung Cancer Survival Rate Tumor & Cancer. Tarceva Lifts Lung Cancer Survival Rate by 42%-NEW ORLEANS — Using Tarceva fostered survival by 42% in patients with end stage non-small-cell lung cancer, according to clinical data presented Saturday at the annual meeting of the American Society of Clinical Oncology (ASCO). […]